Aligos Therapeutics (ALGS) vs Impact BioMedical (IBO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aligos Therapeutics (ALGS) has outperformed Impact BioMedical (IBO) over the past year, losing 46.5% versus a loss of 47.4%. Impact BioMedical is the larger company by market cap ($35.1 million vs $33.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALGS | IBO |
|---|---|---|
| Share price | $5.31 | $4.11 |
| Market cap | $33.16M | $35.11M |
| 1-day change | -0.19% | -8.26% |
| YTD return | -43.03% | -35.70% |
| 1-year return | -46.53% | -47.38% |
| 5-year return | -98.66% | — |
| P/E ratio (TTM) | — | 0.37 |
| EPS (TTM) | $-7.41 | $11.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.69 | $10.51 |
| 52-week low | $3.98 | $4.10 |
| Distance from 52-week high | -61.21% | -60.88% |
| Analyst consensus | none | — |
| Avg. price target upside | +886.44% | — |
| Average volume | 88.98K | 11.61K |
| Shares outstanding | 5.44M | 8.54M |
| Employees | 82 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aligos Therapeutics
ALGS stock →Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity.
Healthcare · Biotechnology · 82 employees
About Impact BioMedical
IBO stock →Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.
Healthcare · Biotechnology · 2 employees
ALGS vs IBO FAQ
Which is bigger, Aligos Therapeutics or Impact BioMedical?
Impact BioMedical (IBO) is larger, with a market capitalization of $35.11M compared with $33.16M for Aligos Therapeutics (ALGS).
Which stock has performed better over the past year, ALGS or IBO?
ALGS returned -46.53% over the past 12 months, compared with -47.38% for IBO (price return, excluding dividends). Past performance does not predict future results.
Are Aligos Therapeutics and Impact BioMedical in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.